Ingenuity canonical pathways | p-Value | Ratio |
---|---|---|
Integrin Signaling | 3.28E-16 | 94/208 |
Protein Ubiquitination Pathway | 3.62E-12 | 103/268 |
Wnt/β-catenin Signaling | 5.57E-11 | 75/175 |
mTOR Signaling | 6.06E-06 | 68/211 |
TGF-β Signaling | 7.22E-06 | 36/89 |
Ephrin B Signaling | 2.46E-05 | 32/82 |
Actin Cytoskeleton Signaling | 3.04E-05 | 72/239 |
IGF-1 Signaling | 6.53E-05 | 38/105 |
Glycolysis | 1.01E-04 | 14/41 |
VEGF Signaling | 1.03E-04 | 36/104 |
AMPK Signaling | 4.67E-04 | 46/169 |
Calcium Signaling | 6.03E-04 | 58/213 |
Insulin Receptor Signaling | 1.22E-03 | 44/142 |
FGF Signaling | 1.53E-03 | 31/92 |
Chemokine Signaling | 1.72E-03 | 26/73 |
PI3K/AKT Signaling | 1.75E-03 | 41/144 |
Fatty Acid β-oxidation | 1.99E-03 | 14/45 |
Hypoxia Signaling in the Cardiovascular System | 4.35E-03 | 24/67 |
PDGF Signaling | 4.63E-03 | 27/85 |
HIF1α Signaling | 9.07E-03 | 33/108 |
Notch Signaling | 9.60E-03 | 15/43 |
Angiopoietin Signaling | 3.00E-02 | 21/74 |